| Stage | SENEB | % of rev | SJM | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $405M | 100.00% | $2.2B | 100.00% | SJM ×5.48 |
| Gross profit | $48M | 11.81% | $980M | 44.14% | SJM +32.3pp |
| Operating income | $26M | 6.47% | $512M | 23.05% | SJM +16.6pp |
| Pre-tax income | $26M | 6.43% | $428M | 19.28% | SJM +12.9pp |
| Net income | $20M | 4.81% | $324M | 14.61% | SJM +9.8pp |
| Stage | SENEB | SJM | Gap · A − B |
|---|---|---|---|
| Revenue | $405M100.00% | $2.2B100.00% | SJM ×5.48 |
| Gross profit | 11.81%$48M | 44.14%$980M | SJM +32.3pp |
| Operating income | 6.47%$26M | 23.05%$512M | SJM +16.6pp |
| Pre-tax income | 6.43%$26M | 19.28%$428M | SJM +12.9pp |
| Net income |
| 4.81%$20M |
| 14.61%$324M |
| SJM +9.8pp |
None
No disclosed counterparties: SENEB.